Zinc is essential for cell proliferation. Several human studies have shown that in breast cancer tissues, zinc concentration expressed on a per tissue weight basis is higher than that in normal breast tissues. However, the mechanisms involved are unknown. N-methyl-N-nitrosourea (MNU)-induced rat mammary tumorigenesis is one of the most widely used rodent mammary tumorigenesis models for studying human breast cancer due to their similarities in hormone dependency, pathogenesis, histological classification, and immunocytochemical markers. This study was to establish if there was an accumulation of zinc in MNU-induced rat mammary tumors and, if there was, to explore the possible mechanisms involved. Sprague-Dawley rats were sham-treated or MNU-treated (50 mg/kg; n = 12) for 100 days. In MNU-induced mammary tumors (mammary tumors), zinc concentration expressed on a per dry weight basis was 12 times of that in normal mammary glands. Moreover, the mRNA level of ZnT-1 (a transporter involved in zinc efflux) in mammary tumors was reduced by 55% as compared with that in normal mammary glands. The mRNA level of Nramp2 (a divalent cation importer) and ZnT-4 (another transporter involved in zinc efflux) was unaffected by MNU-induced mammary tumorigenesis. The mRNA and protein levels of metallothionein (a putative zinc storage protein) in mammary tumors were 1.3 and 3.5 times of that in normal mammary glands, respectively. Collectively, our observations showed that zinc is accumulated in MNU-induced rat mammary tumors and this accumulation is accompanied by an altered expression of ZnT-1 and metallothionein, suggesting that zinc homeostasis might be altered in MNU-induced rat mammary tumorigenesis. Because zinc is essential to cell proliferation and cell proliferation is increased in mammary tumors, zinc accumulation is likely a part of an integrated effort to ensure sufficient zinc supply to sustain tumor growth.
SantoliquidoPM, SouthwickHW, OlwinJH. Trace metal levels in cancer of the breast. Surg Gynecol Obstet142: 6570, 1976.
7.
MargaliothEJ, SchenkerJG, ChevionM. Copper and zinc levels in normal and malignant tissues. Cancer52: 868872, 1983.
8.
BorellaP, BargelliniA, CaselgrandiE, PiccininiL. Observations on the use of plasma, hair and tissue to evaluate trace element status in cancer. J Trace Elements Med Biol11: 162165, 1997.
9.
MulayIL, RoyR, KnoxBE, ShurNH, DelaneyWE. Trace metal analysis of cancerous and non-cancerous human tissues. J Natl Cancer Inst47: 113, 1971.
10.
RizkSL, Sky-PeckHH. Comparison between concentrations of trace elements in normal and neoplastic human breast tissue. Cancer Res44: 53905394, 1984.
11.
NgK-H, BradleyDA, LooiL-M, MahmoodCS, WoodAK. Differentiation of elemental composition of normal and malignant breast tissue by instrumental neutron activation analysis. Appl Radiat Isot44: 511516, 1993.
12.
van RigAM, PoriesWJ. Zinc and tumor growth. In: SigelH, Ed. Metal Ions in Biological Systems. New York: Marcel Dekker, pp 207251, 1980.
13.
CooperGM. Classification and development of neoplasms. In CooperGM, Ed. Elements of Human Cancer. Boston: Jones and Barlett Publishers, p 20, 1992.
14.
WalshCT, SandsteadHH, PrasadAS, NewbernePM, FrakerPJ. Zinc: health effects and research priorities for the 1990s. Environ Health Perspect102(Suppl 2):546, 1994.
15.
GunshinH, MackenzieB, BergerUV, GunshinY, RomeroMF, BoronWF, NussbergerS, GollanJL, HedigerMA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature388: 482488, 1997.
16.
GaitherLA, EideDJ. Eukaryotic zinc transporters and their regulation. BioMetals14: 251270, 2001.
17.
PalmiterRD, FindleySD. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J14: 639649, 1995.
18.
PalmiterRD, ColeTB, FindleySD. ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO J15: 17841791, 1996.
19.
PalmiterRD, ColeTB, QuaifeCJ, FindleySD. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci U S A93: 1493414939, 1996.
20.
HuangL, GitschierJ. A novel gene involved in zinc transport is deficient in the lethal milk mouse. Nature17: 292297, 1997.
21.
KambeT, NaritaH, Yamaguchi-IwaiY, HiroseJ, AmanoT, SugiuraN, SasakiR, MoriK, IwanagaT, NagaoM. Cloning and characterization of a novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in pancreatic beta cells. J Biol Chem277: 1904919055, 2002.
22.
CherianMG, ChanHM. Biological functions of metallothionein: a review. In: SuzukiKT, ImuraN, KimuraM, Eds. Metallothionein III: Biological Roles and Medical Implications. Berlin: Birkhauser Verlag, pp 87109, 1993.
23.
ChestersJK, PetrieL, LipsonKE. Two zinc-dependent steps during G1 to S phase transition. J Cell Physiol155: 445451, 1993.
PaskiS, XuZ. Labile intracellular zinc is associated with 3T3 cell growth. J Nutr Biochem12: 655661, 2001.
26.
RussoJ, GustersonBA, RogersAE, RussoIH, WellingsSR, van ZwietenMJ. Comparative study of human and rat mammary tumorigenesis. Lab Invest62: 244278, 1990.
27.
GouldMN. Rodent models for the study of etiology, prevention and treatment of breast cancer. Semin Cancer Biol6: 147152, 1995.
28.
NandiS, GuzmanRC, YangJ. Hormones and mammary carcinogenesis in mice, rats and humans: a unifying hypothesis. Proc Natl Acad Sci U S A92: 36503657, 1995.
29.
ThompsonHJ, AdlakhaH. Dose-responsive induction of mammary glands carcinomas by the intraperitoneal injection of 1-methyl-1-nitrosourea. Cancer Res51: 34113415, 1991.
30.
CleggMS, KeenCL, LonnerdalB, HurleyLS. Influence of ashing techniques on the analysis of trace elements in animal tissue. Biol Trace Element Res3: 107115, 1981.
31.
LowryOH, RosebroughNJ, FarrAL, RandallRJ. Protein measurement with the Folin phenol reagent. Anal Biochem193: 265275, 1951.
32.
FolchJ, LeesM, SloanestanleyGH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem226: 497509, 1957.
33.
EatonDL, TotalBF. Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biological tissues. Toxicol Appl Pharmacol66: 134142, 1982.
34.
EatonDL, CherianMG. Determination of metallothionein in tissues by cadmium-hemoglobin affinity assay. In: RiordanJF, ValleeBL, Eds. Methods in Enzymology. New York: Academic Press, Part B205, pp 8388, 1991.
35.
ChomczynskiP, SacchiN. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem162: 156159, 1987.
36.
CliffordKS, MacDonaldMJ. Survey of mRNAs encoding zinc transporters and other metal complexing proteins in pancreatic islets of rats from birth to adulthood: similar patterns in the Sprague-Dawley and Wistar BB strains. Diabetes Res Clinical Practice49: 7785, 2000.
37.
MahnkeA, StrotkampD, RoosPH, HansteinWG, ChabotGG, NefP. Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch Biochem Biophys337: 6268, 1997.
38.
MoffattP, DenizeauF. Metallothionein in physiological and physiopathological processes. Drug Metab Rev29: 261307, 1997.
39.
BremnerI. Nutritional and physiologic significance of metallothionein. In: RiordanJF, ValleeBL, Eds. Methods in Enzymology. New York: Academic Press, Part B205, pp 2535, 1991.
40.
MenardP, McCormickCC, CousinsRJ. Regulation of intestinal metallothionein biosynthesis in rats by dietary zinc. J Nutr111: 13531361, 1981.
41.
RichardsMP, CousinsRJ. Metallothionein and its relationship to the metabolism of dietary zinc in rats. J Nutr106: 15911599, 1976.
42.
ChestersJK, PetrieL, VintH. Specificity and timing of the Zn2+ requirement for DNA synthesis by 3T3 cells. Exp Cell Res184: 499508, 1989.
43.
WilliamsRB, ChestersJK. The effects of early zinc deficiency on DNA and protein synthesis in the rat. Br J Nutr24: 10531059, 1970.
44.
CherianMG, HuangPC, KlaassenCD, LiuY, LongfellowDG, WaalkersMP. National Cancer Institute Workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res53: 922925, 1993.
45.
GouldingH, JasenB, PereiraH, ReidA, GaleaM, BellJA, ElstonCW, RobertsonJF, BlarneyRW, NicholsonRA, SchmidKW, EllisIO. Metallothionein expression in human breast cancer. Br J Cancer72: 968972, 1995.
46.
JinR, BayBH, ChowVTK, TanPH. Metallothionein 1F mRNA expression correlates with histological grade in breast carcinoma. Breast Cancer Res Trea66: 265272, 2001.
47.
JinR, ChowVTK, TanPH, DheenST, DuanW, BayBH. Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis23: 8186, 2002.
48.
SchmidKW, EllisIO, GeeJMW, DarkeBM, LeesWE, KayJ, CryerA, StarkJM, HittmairA, OfnerD, DunserM, MargreiterR, DaxenbichlerG, NicholsonRI, BierB, BockerW, JasaniB. Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Arch A Pathol Anat422: 153159, 1993.
49.
SensMA, SomjiS, GarrettSH, BeallCL, SensDA. Metallothionein isoform 3 overexpression is associated with breast cancer having a poor prognosis. Am J Pathol159: 2126, 2001.
50.
ZhangR, ZhangH, WeiH, LuoX. Expression of metallothionein in invasive ductal breast cancer in relation to prognosis. J Environ Pathol Toxicol Oncol19: 9597, 2000.
51.
GroganTM, LippmanSM, SpierCM, SlymenDJ, RybskiJA, RangelCS, RichterLC, MillerTP. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood71: 11571160, 1988.
52.
CherianMG, HowellSB, ImuraN, KlaassenCD, KoropatnickJ, LazoJS, WaaljesMP. Role of metallothionein in carcinogenesis. Toxicol Appl Pharmacol126: 15, 1994.
53.
Adbel-MageedA, AgrawalKC. Antisense down0regulation of metallothionein induces growth arrest and apoptosis in human breast cancer carcinoma cells. Cancer Gene Ther4: 199207, 1997.
54.
PhilcoxJC, TilleyMH, CoyleP, RofeAM. Metallothionein and zinc homeostasis during tumor progression. Biol Trace Element Res40: 295305, 1994.
55.
LiuzziJP, BlanchardRK, CousinsRJ. Differential regulation of zinc transporter 1, 2, and 4 mRNA expression by dietary zinc in rats. J Nutr131: 4652, 2001.
